Clinical Trial Update: Preoperative Treatment With Cetuximab and/or IMC-A12 [Phase 2]

View source ↗

Summary

Phase 2 trial update examining preoperative treatment with cetuximab and/or IMC-A12 in head and neck squamous cell carcinoma; study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• IMC-A12 (cixutumumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-03-19